The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.
News-Medical.Net on MSN
Study validates OVCAR3 as a model for high-grade serous ovarian cancer
A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...
A newly discovered genetic mutation unique to humans may help explain why we are significantly more vulnerable to cancer than our closest evolutionary relatives. Researchers at the University of ...
Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma. In a post on social media on ...
6don MSN
Some mammals can hit pause on a pregnancy—understanding how that happens could help us treat cancer
Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...
Cold Spring Harbor Laboratory Associate Professor Camila dos Santos recently found that inhibiting a protein called BPTF forces cancer to stay in a state that could reduce metastasis and make it more ...
Small cell lung cancer (SCLC) is one of the most dangerous forms of lung cancer. It grows and spreads very quickly. Sadly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback